Decreased Semen Volume Research Articles

Effect of paternal overweight or obesity on semen parameters, clinical pregnancy and live birth outcomes in men treated with intrauterine insemination (IUI).

Overweight and obese individuals are steadily increasing in recent years. Male overweight or obesity has adverse impact on reproductive functions. The study aimed to evaluate the potential impact of paternal overweight or obesity on sperm quality and clinical pregnancy outcome in patients undergoing intrauterine insemination (IUI) treatment. This retrospective study included 1,036 couples from our reproductive center between July 2019 and August 2022. All males were categorized into normal weight, overweight, or obese groups according to their body mass index (BMI). Baseline characteristics and reproductive hormones were analyzed. Semen parameters, clinical pregnancy and live birth outcomes were compared among the different BMI groups. There were no significant differences in sperm concentration, total sperm motility, progressive sperm motility, normal sperm morphology and sperm DNA fragmentation index (DFI) among the three groups. However, the obese group exhibited a significantly decreased semen volume compared to the other two groups (P<0.01). No differences were found in clinical pregnancy rate (CPR), abortion rate (AR) and live birth rate (LBR) among the groups (P>0.05). Slight higher ARs were observed in overweight and obese groups compared to normal group (13.64%, 21.05% vs. 11.11%, P=0.49). These data suggest that male obesity leads to a significant decrease in semen volume. It is thus recommended that male BMI should be regarded as one of the predictors for IUI treatment to avoid a decrease in semen volume.

Patterns of alteration in boar semen quality from 9 to 37 months old and improvement by protocatechuic acid

BackgroundComprehending the patterns of alteration in boar semen quality and identifying effective nutritional interventions are crucial for enhancing the productivity of commercial pig systems. This study aimed to examine the alteration in semen quality in boars, and assess the impact of protocatechuic acid (PCA) on semen quality during the phase of declining semen quality.MethodsIn Exp. 1, a total of 38 Pig Improvement Company (PIC) boars were selected and their semen quality data were recorded from the age of 9 to 37 months. In Exp. 2, 18 PIC boars (28 months old) were randomly assigned into three groups (n = 6) and fed a basal diet, a basal diet containing 500 or 1,000 mg/kg PCA, respectively. The experiment lasted for 12 weeks.ResultsThe semen volume, concentration, and total number of spermatozoa in boars exhibited an increase from 9 to 19 months old and showed a significant linear decreased trend in 28, 24, and 22 months old. Sperm motility displayed an upward trajectory, reaching its peak at 20 months of age, and showed a significant linear decreased trend at 20 months old. Dietary supplementation of PCA demonstrated an effect to mitigate the decrease in semen volume, concentration of spermatozoa, total number of spermatozoa (P > 0.05), and significantly increased the sperm motility (P < 0.05). Moreover, supplementation of 1,000 mg/kg PCA significantly increased the sperm viability (P < 0.05). Analysis on cellular signaling pathways revealed that PCA restored serum testosterone levels and alleviated oxidative damage by upregulating the expression of HO-1, SOD2, and NQO1 in testicular stromal cells. Notably, PCA can enhance phosphorylation by selectively binding to AMP-activated protein kinase (AMPK) protein, thereby improving sperm mitochondrial function and augmenting sperm motility via PGC-1/Nrf1.ConclusionsThese data elucidated the pattern of semen quality variation in boars within the age range of 9 to 37 months old, and PCA has the potential to be a natural antioxidant to enhance sperm quality through modulation of the AMPK/PGC-1/Nrf1 signaling pathway.

285 Impact of feeding strategies on semen concentration, motility, and morphology of the mature AI boar

Abstract The objective of this experiment was to determine if varying feeding strategies of maintenance requirements of boars impacts semen concentration, motility, morphology, and cortisol of the working boar. This experiment was conducted at Purdue University over two 9-wk periods with 1-wk before each 9-wk period serving as baseline for analysis. Boars (n = 28; Acuity and Topig Norvsin) from two age groups (9 and 15 mo) and two genetics (maternal and terminal) were used. Boars were blocked by breed and age and randomly allocated to receive one of three feed intake levels of a corn-soybean meal-based diet formulated to meet NRC (2012) maintenance requirements: HIGH (150% maintenance, n = 9); MAIN (100% maintenance, n = 10); and LOW (80% maintenance, n = 9) during the first 9-wk period. During the second 9-wk period remaining HIGH and LOW boars were crossed-over to opposite treatments (HIGH-LOW, n = 9; LOW-HIGH, n = 7), and maintenance boars were unchanged (MAIN-MAIN, n = 8). Semen was collected once/wk using the gloved hand method and 3 mL of ejaculate was diluted in 27 mL of extender (Androhep Plus, Minitube). Semen concentration (Nucleocounter SP-100), motility (Computer Assisted Sperm Analysis, CASA, CEROS II), and sperm cell morphology (phase-contrast, bright-field microscopy) were analyzed. Data were analyzed using PROC MIXED in SAS 9.4 with boar as experimental unit with main effects of feed intake and age with phase (3-wk period) as repeated measure. Significance was determined at P &amp;lt; 0.05 and a trend 0.05 &amp;lt; P ≤ 0.10. Three-way interactions for the first 9-wk period of feed intake*age*phase was observed for total sperm (P &amp;lt; 0.10) and total normal sperm (P &amp;lt; 0.05) with old boars fed HIGH treatment increasing sperm production, but old boars fed MAIN and LOW decreasing sperm production while young boars had minimal changes in sperm production regardless of feeding levels in the first 9-wk period. No other interactions or main effects were observed for the first period. During the second 9-wk period two-way interactions were observed for total sperm (FI*Age; P &amp;lt; 0.05) and total normal sperm (FI*Age; P &amp;lt; 0.01) with old LOW-HIGH boars having the highest total sperm and total normal sperm concentrations and young LOW-HIGH boars having the least total sperm and total normal sperm concentrations. HIGH-LOW fed boars had the greatest decrease in semen volume compared with the other treatments (FI*Phase; P &amp;lt; 0.01). Boars fed MAIN had minimal impacts on semen parameters compared with HIGH and LOW feed intake treatments. HIGH and LOW feed intake was observed to impact semen parameters in old boars faster than young boars with neither age being able to return to their baseline semen parameters observed at the start of the trial. Future research is needed with varying ages and feed intakes to better understand how nutritional strategies impact semen quantity and quality in the boar stud.

Intra-individual changes in sperm parameters and total motile count with time among infertile men.

Paternal age association with sperm parameters has been previously studied, demonstrating a decrease in semen volume, sperm motility, and sperm morphology, but not in sperm concentration. However, scarce data exists on the individual intra-personal changes in semen parameters with time. Retrospective cohort study. To evaluate the changes in semen parameters and total motile count of infertile men over time. In this retrospective cohort study, infertile men without known risk factors for sperm quality deterioration and at least two semen analyses done>3 months apart, between 2005 and 2021, were evaluated. Allocation to groups was according to time between first and last semen analyses - 3-12 months, 1-3 years, 3-5 years, and>5 years. Basic characteristics and first and last semen analyses were compared. The primary outcome was the change in sperm parameters and the secondary outcome was the occurrence of a total motile count<5 million in men with an initial total motile count>10 million. A total of 2018 men were included in the study. The median age at first semen analyses was 36.2 (interquartile range: 32.8-40.1) years and the median time between semen analyses was 323 days (range 90-5810 days).The overall trend demonstrated an increase in concentration in the 3-12 months and the 1-3 years groups, whereas volume, motility, and morphology remained similar in these time groups. Semen analyses done more than 5 years apart showed decreased volume (p<0.05), motility (p<0.05) morphology (p<0.05), and steady sperm concentration. Significant declines in TMCs were found over time (p<0.001), with 18% and 22% of infertile men with an initial total motile count>10 million dropping to<5 million after 3 and 5 years, respectively. The factors independently predictive of total motile count<5M in the last semen analyses in men with an initial total motile count of>10M in a multivariate logistic regression model were baseline volume (odds ratio 0.80, p=0.03), baseline total motile count (odds ratio 0.98, p=0.01) and time between semen analyses - 3-5 years (odds ratio 3.79, p<0.001) and>5 years (odds ratio 3.49, p=0.04) DISCUSSION: Our study demonstrates, at the individual level, that while improvement in sperm concentration is observed in the first year and between 1 and 3 years, possibly due to fertility treatments, fertility-related counseling, and lifestyle changes, semen parameters decline with time over 3 years in individuals. Of significance, close to 22% of men with an initial total motile count>10 million (a range where spontaneous pregnancy is attainable) declined to<5 million (a range usually indicating a need for in-vitro fertilization/intracytoplasmic sperm injection) over 5 years. This data could contribute to individualized family planning for infertile men regarding the mode and timing of conception and the need for sperm banking, in order to minimize the need for future fertility treatments.

Insulin-like growth factor-1 promotes the testicular sperm production by improving germ cell survival and proliferation in high-fat diet-treated male mice.

A decrease in semen volume among men is comparable to the rising prevalence of obesity worldwide. The anabolic hormone insulin-like growth factor-1 (IGF-1) can promote proliferation and differentiation in cultured mouse spermatogonial stem cells and alleviate abnormal in vitro spermatogenesis. Additionally, serum IGF-1 level is negatively correlated with body mass index. Whereas the role of IGF-1 in the sperm production in obese men remains unclear. To investigate the therapeutic effect and potential mechanism of IGF-1 on spermatogenesis of high-fat diet (HFD)-induced obesity mice. An HFD-induced obesity mouse model was established. Alterations in testicular morphology, sperm count, proliferation, and apoptosis were observed by H&E staining,immunohistochemistry, immunofluorescence, and Western blotting. Exogenous recombinant IGF-1 was administered to obese mice to investigate the correlations between altered testicular IGF-1 levels and sperm production. The sperm count was reduced, the testicular structure was disordered, and sex hormone levels were abnormal in HFD-fed mice compared with normal diet-fed mice. The expression of proliferation-related antigens such as proliferating cell nuclear antigen (PCNA) and Ki-67 was decreased, while that of proapoptotic proteins such as c-caspase3 was increased in testes from HFD-fed mice. Most importantly, the phosphorylation of insulin-like growth factor-1 receptor (IGF-1R) in testes was decreased due to reductions in IGF-1 from hepatocytes and Sertoli cells. Recombinant IGF-1 alleviated these functional impairments by promoting IGF-1R, Akt, and Erk1/2 phosphorylation in the testes. Insufficient IGF-1/IGF-1R signaling is intimately linked to damaged sperm production in obese male mice. Exogenous IGF-1 can improve survival and proliferation as well as sperm production. This study provides a novel theoretical basis and a target for the treatment of obese men with oligozoospermia.

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification.

Transurethral resection of ejaculatory duct (TURED) is a primary surgical approach to treat ejaculatory duct obstruction (EDO) caused by the ejaculatory duct cyst. Intraoperative excision of the verumontanum is usually required to expose the ejaculatory ducts. However, preserving the verumontanum structure allows for a better simulation of normal physiological anatomy. Maintaining the verumontanum may increase the risk of postoperative distal ejaculatory duct scarring, leading to recurrent obstruction or reduced semen volume. Therefore, we attempted a novel technique that preserves the verumontanum, which is relatively easier and safer compared to TURED. The following were the procedural steps: 1. A 6F seminal vesiculoscope was introduced through the external urethral orifice to the vicinity of the verumontanum, locating the opening of the affected-side ejaculatory duct and introducing a guidewire into the cyst. This successful step preserved the verumontanum, maximizing the retention of the anti-reflux mechanism in the distal ejaculatory duct. 2. The holmium laser enlarged the affected-side ejaculatory duct opening to 5 mm, decreasing the likelihood of postoperative closure of the ejaculatory duct opening and simplifying the procedure. 3. A window was created within the cyst to access the contralateral seminal vesicle, and then a holmium laser was used to burn and dilate the opening to 5 mm, redirecting the contralateral ejaculatory duct into the cystic cavity. This modification preserved the opening of the healthy-side ejaculatory duct and provided a new outflow passage for semen, reducing the risk of decreased semen volume postoperatively. The patients experienced no complications postoperatively, had shorter hospital stays, and showed improvement in semen volume. Hence, this surgical approach is simple yet effective.

Effects of cigarette smoking on semen quality, reproductive hormone levels, metabolic profile, zinc and sperm DNA fragmentation in men: results from a population-based study.

Cigarette smoking seems to have a negative impact on men's reproductive health, but our knowledge of its effects on the reproductive function of Russian men is still very limited. The purpose of this study was to evaluate the effect of cigarette smoking on semen quality, including sperm DNA fragmentation, hormonal, zinc and metabolic status in young men from the general multi-ethnic Russian population (n=1,222, median age 23 years) and to find out the ethno-specific effects of smoking by comparing male groups of different ethnicity. Each participant filled out a standardized questionnaire, provided one blood and semen sample. Semen parameters, serum reproductive hormones, lipids, glucose, uric acid and seminal zinc were analyzed. Participants were classified as smokers (n=450) and non-smokers (n=772), and smokers were stratified into moderate (≤10 cigarettes/day) and heavy (>10 cigarettes/day) smokers. In the entire study population, heavy smokers were characterized by a decrease in semen volume, total sperm count, sperm concentration and motility, and an increase in sperm DNA fragmentation and teratozoospermia compared with non-smokers (p<0.05). There was also a reduction in the serum and seminal zinc level as well as an impairment in metabolic health in smokers compared with non-smokers (p<0.05). No significant differences between smokers and non-smokers were found for serum levels of LH, FSH, inhibin B, testosterone and estradiol. In the second part of our study, the most numerous ethnic groups of Slavs (n=654), Buryats (n=191), and Yakuts (n=125) were selected from the entire study population. Among three ethnic groups, the smoking intensity was higher in Slavs than in Buryats or Yakuts suggesting a greater tobacco addiction in Slavs than in Asians. A decrease in semen parameters and seminal zinc levels, and an increase in sperm DNA fragmentation and teratozoospermia was observed only in smoking Slavs (p<0.05); moderate decrease in testosterone and increase in triglyceride levels were revealed in smoking Yakuts (p<0.05), but no significant changes were detected in smoking Buryats. We concluded that cigarette smoking has an ethno-specific effect on male reproductive function, probably due to the different activity of the seminal antioxidant system, which is yet to be elucidated.

Comparison of semen parameters in the same patients before and after diagnosis of COVID-19.

Clinical and histopathological evidence suggest that the male reproductive system may be negatively impacted in patients with coronavirus disease (COVID-19). The objective of this study is to investigate the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on semen parameters by comparing semen analyses before and after COVID-19 diagnosis in the same patient. We retrospectively analyzed 342 semen analyses by reviewing medical records. The study included two groups of patients: (i) those who underwent two consecutive semen analyses within 6 months, one before (n = 114) and one after (n = 114) COVID-19 diagnosis, and (ii) a control group (n = 114) that was age-matched and did not receive a diagnosis of COVID-19. The study results indicated a significant decrease in semen volume, total sperm count per ejaculate, progressive motile sperm count, total motile sperm count, and normal sperm morphology after SARS-CoV-2 infection in comparison to their respective values before the infection. Subgroup analyses showed that the duration of COVID-19 diagnosis (short-term vs. long-term) did not impact the changes in semen parameters. However, fever during the COVID-19 process had a negative effect on semen parameters, particularly sperm concentration, unlike in patients without fever. In conclusion, our findings suggest that SARS-CoV-2 infection is associated with a decline in semen quality, which may potentially impact male fertility. Furthermore, it's important to note that the negative effects on semen parameters may persist in the long-term. Our results also indicate that fever during active infection could be a significant risk factor that negatively affects spermatogenesis.

P-088 The Paternal Clock: Shedding Light on the Relationship Between Paternal Age and Sperm DNA Fragmentation

Abstract Study question What is the impact of advanced paternal age (APA) on sperm DNA fragmentation index (DFI)? Summary answer Sperm DFI levels remain relatively stable until the age of 35 and increase progressively beyond that age. What is known already APA can have a negative impact on male fertility and the health of offspring. Previous studies have shown that APA is linked to poor conventional sperm parameters, including decreased semen volume, sperm count, motility, morphology, as well as poor sperm DNA integrity. Additionally, APA has been associated with reduced natural or assisted reproduction and perinatal outcomes and a higher risk of genetic and chromosomal abnormalities in the offspring. Study design, size, duration A retrospective cohort study of 4250 consecutive semen samples from men undergoing infertility evaluation at the OVO clinic, in Montreal, Canada, between April 2016 and December 2022. Participants were stratified into seven age groups: &amp;lt;26 (n = 36; 0,8%), 26-30 (n = 500; 11,8%), 31-35 (n = 1269; 29,9%), 36-40 (n = 1268; 29,8%), 41-45 (n = 732; 17,2%), 46-50 (n = 304; 7,2%), &amp;gt;50 years (n = 141; 3,3%). The mean age was 37.4 ± 6.4 years (range 18-71 years). Participants/materials, setting, methods The study was population-based and included male patients from all ages, ethnicities, and medical histories. Semen samples were collected after 2-3 days of abstinence. For patients who underwent more than one DFI testing, only the first sample was included, and any duplicates were excluded. DFI was evaluated by flow-cytometry based TUNEL assay using the APO-Direct Kit. Data were analyzed using one-way ANOVA and T3 Dunnett post-hoc multiple comparison test, as well as Pearson’s correlation coefficient. Main results and the role of chance The results show a significant positive correlation between %DFI and age (r = 0.19, p &amp;lt; 0.001). Mean %DFI levels were relatively stable in men aged &amp;lt;26 to 35 years (17.9%, 18.1% and 18.1% in men aged &amp;lt;26, 26-30 and 31-35, respectively), with %DFI increasing progressively beyond age 35 (20.7%, 22.5%, 25.7% and 27.9% in men aged 36-40, 41-45, 46-50 and &amp;gt;50, respectively). The mean %DFI in the 36-40 age group was significantly higher than in the 31-35 age group (p &amp;lt; 0,001). Our study has uncovered that %DFI follows an exponential curve starting at age 35, indicating that the %DFI accelerates significantly as men age beyond their mid-30s. Limitations, reasons for caution This retrospective analysis has inherent limitations that may introduce confounding variables. The patient clinical background, such as medical history and lifestyle factors was not assessed. Also, the studied cohort consisted of a population under investigation for infertility and may not be representative of the general male population. Wider implications of the findings The study demonstrates the age-related increase in sperm %DFI and suggests that there may be an age cut-off below which sperm %DFI is stable and beyond which sperm %DFI increases. This information may be useful to medical specialists that offer sperm DNA testing to infertile couples. Trial registration number not applicable

Decline of Sperm Quality over the Last Two Decades in the South of Europe: A Retrospective Study in Infertile Patients.

Semen quality has a direct relation to male fertility. Whether sperm variables in humans have decreased over the last years is still uncertain, with some studies showing a decline and others reporting no changes. In this regard, previous research has suggested that lifestyle and environmental conditions may contribute to this variability, calling for regional studies. The present work is a retrospective, unicentric study that includes semen samples analyzed between 1997 and 2017 at the Parc Taulí Hospital (Barcelona metropolitan area). First, a multivariate analysis including the age as a confounding factor showed a statistically significant decrease in semen volume, pH, progressive motility, morphology and total motile sperm over time. Contrarily, no significant variation in sperm count or concentration was observed. Mean reductions per year were -0.02 mL for volume, -0.57% for progressively motile sperm and -0.72% for sperm with normal morphology. Interestingly, the average annual temperature registered by the Spanish Meteorology Agency negatively correlated to sperm morphology and sperm count (Rs = -0.642; p = 0.002 and Rs = -0.435; p = 0.049, respectively). In conclusion, the present study based on infertile patients from the Barcelona area found a decline in sperm motility and morphology, without effects on sperm count. Changes in temperature appeared to be associated to this decline, but further studies are needed to address the mechanisms linked to the observed variations.

Changes of sperm parameters in men recovered from coronavirus disease 2019 (covid-19): a comparison between precovid and postcovid period

The Coronavirus disease 2019 (COVID-19), which is the cause of a global pandemic, is thought to damage the male reproductive system via both direct and indirect pathways, according to several hypotheses. However, there are very limited studies in the literature examining the changes in male sperm parameters before and after COVID-19. The aim of this study is to evaluate the effect of COVID-19 on male reproductive health. The men included in the male sexual health cohort of our clinic within the last 6 months were screened, retrospectively. 25 individuals with a history of COVID-19 following the first clinical evaluation who did not have active symptoms at the present were invited to be examined in the 3rd month after COVID-19. The spermiogram parameters of the subjects in the last 6 months before COVID-19 and in the 3rd month after COVID-19 were compared. In addition, SARS CoV-2 PCR analysis was performed on semen samples of all participants. The study group had a mean age of 34.8±7.7, a mean BMI of 26.82±5.3, a Charlson comorbidity index score of 0.16±0.37, and a paternity ratio of 8/25 (32%). COVID-19 severity was mild in 19/25 (76%) of the participants and moderate in 6/25 (24%), with a mean COVID-19 duration of 9.2±5.42 days. The SARS CoV-2 PCR test was negative in the semen samples of all subjects. Although the sperm morphology did not alter, there was a statistically significant decrease in semen volume and sperm concentration, as well as progressive and total sperm motility in the postcovid period compared to the precovid period of the same subject (p<0.05; p<0.05; p<0.01; p<0.01, respectively). In males who recovered from COVID-19, all spermiogram parameters except sperm morphology were impaired. Long-term cohort studies in larger populations are required to determine whether this deterioration is permanent. The authors declare no conflict of interest.

Relationships between semen quality and fertility in a population of infertile men in Erbil city.

The evaluation and the relationships between human semen quality and fertility in infertile males in Erbil city of Iraq is the aim of the present study. Semen quality and fertility were estimated by using semen analysis. The semen analysis parameters were including; the volume of the semen, and sperm (count, motility, morphology, and viability). For this purpose, one hundred fifty infertile and fifty fertile adult males participated. The study was performed from September 2021 to April 2022 in the Infertility care and In vitro fertilization center (IVF). A significant negative correlation was found between infertility% with decreased semen volume (r = - 0.58, p≤0.05), sperm concentration (r = - 0.74, p ≤0.001), total sperm count (r = - 0.68, p≤0.001), sperm morphology (r = - 0.57, p ≤0.01), sperm viability (r = - 0.80, p ≤0.001), total sperm motility (r = -0.80, p ≤0.001), and progressive motility (r = - 0.78, p≤0.001). Regarding fertility. A significant positive correlation was found between fertility% with increased semen volume (r = 0.64, p ≤0.05), sperm concentration (r = 0.76, p ≤0.001), total sperm count (r = 0.78, p ≤0.001), sperm morphology (r = 0.48, p ≤0.01), sperm viability (r = 0.70, p ≤0.001), total sperm motility (r = 0.84, p ≤0.001), and progressive motility (r = 0.75, p ≤0.001. The prevalence of hypospermia, oligozoospermia, teratozoospermia, low sperm viability, and low sperm motility kinetics (asthenozoospermia) in infertile males is significantly higher than that of fertile men.

Partial Gland Ablation of Prostate Cancer: Effects of Repeat Treatment

To evaluate the near-term clinical and pathological effects of repeat partial gland ablation (PGA) in men with intermediate-risk prostate cancer (PCa). One hundred seventy men with focal lesions of PCa (all GG2 or GG3) underwent PGA with high-intensity focused ultrasound (HIFU) or cryotherapy (CRYO) in prospective trials. Residual PCa in or near the ablation zone was found in 37 men after a first PGA; 30 went on to receive a second PGA and were the subjects of study. At 3 timepoints, baseline and 6 months after first and second ablations, quality-of-life (QOL) questionnaires (IIEF, IPSS) and MRI-guided biopsies (MRGB) were performed. Biopsies were targeted and systematic at baseline and in follow-up, comprehensively about the ablation zone. All 30 patients completed QOL questionnaires and 26 had MRGB at the 3 timepoints. Mean QOL scores were not significantly different from the baseline after the first or second PGA. No operative complications were encountered; and "decisional regret" was reported in only 2/29 men after the repeat ablation. A decrease in semen volume was reported by 25% of patients. Repeat ablation was successful (absence of csPCa on MRGB) in 14/26 (53%) of men. PSA levels decreased and MRI lesions resolved after ablations, but neither was a reliable predictor of biopsy outcomes. When initial PGA fails, repeat PGA is a reasonable consideration, because in near-term follow-up, secondary procedures appear to be safe, causing only minimal detriment to urinary and sexual function, with csPCa becoming undetectable by MRGB in approximately half the patients.

Effects of different feeding systems on growth, fat accumulation and semen quality of Merino-type sheep

In South Africa, supplemental feeding is provided to improve the condition of breeding livestock before the animals are sold by the stud breeders to commercial farmers. This study aimed to evaluate the effects of different ram rearing systems on growth, fat accumulation and semen quality of Döhne Merino (DM), Merino (M) and South African Mutton Merino (SAMM) rams intended for breeding. The ram lambs were stratified according to weight and randomly allocated to one of three treatments, namely an extensive feeding treatment (ET), an extensive-intensive feeding treatment (EIT), and an intensive feeding treatment (IT). Rams in ET grazed for 200 days. Rams in EIT grazed for 73 days, followed by a concentrate diet for an additional 60 days. Rams in IT were fed the concentrate diet for 70 days. Scrotal neck fat was significantly less in IT rams compared with ET and EIT rams. Döhne Merino and M rams in EIT deposited significantly more scrotal fat than DM and M rams in ET. No adverse testicular pathology or differences in semen quality were observed. Regression analyses of pooled data showed extreme functional values for subcutaneous fat and total scrotal fat weight, which, when exceeded, may result in decreased semen volume, percentage normal spermatozoa and mass motility of spermatozoa. Sheep breeders should be cautious when feeding ram lambs in extensive-intensive systems for extended periods since this may affect semen quality adversely.

Evaluation of ejaculation function using a simple questionnaire

ABSTRACT Introduction There is a wide range of problems associated with ejaculation, including decreased semen volume, vaginal ejaculation problems, premature ejaculation, delayed ejaculation, hematospermia, and pain associated with ejaculation. However, there is no simple questionnaire that can comprehensively evaluate these ejaculatory functions. Objective In this study, we evaluated the overall ejaculation function of the patients in question using an originally developed ejaculation function score (Kimura and Shoji's Ejaculation Function Score). Methods We examined 20 patients who visited our sexual function outpatient clinic with a chief complaint of ejaculation. As a control group, we also examined 20 patients who had undergone vasectomy using the same score. The questionnaire consisted of the following five items (1) Awareness of sufficient momentum, (2) Pleasant sensation during ejaculation, (3) Presence of pain associated with ejaculation, (4) Presence of blood in semen, and (5) Perception of decreased semen volume. The total score was also evaluated. In addition, satisfaction with the current ejaculation was assessed. Results The mean age of the ejaculation disorder group was 43.5±15.1 years. The main complaints were decreased semen volume in 7 cases (35%), vaginal ejaculation disorder in 6 cases (30%), delayed ejaculation in 2 cases (10%), premature ejaculation in 2 cases (10%), lack of orgasm in 1 case (5%), and pain associated with ejaculation in 1 case (5%). The mean scores for each item were 1.5 for item 1, 1.8 for item 2, 3.0 for item 3, 3.0 for item 4, and 2.0 for item 5, resulting in a mean total score of 11.2. On the other hand, the mean age of the vasectomy group was 42.0±9.4 years, item 1 was 2.8, item 2 was 2.9, item 3 was 3.0, item 4 was 3.0, item 5 was 2.9, and the mean total score was 14.6. When the two groups were compared, significant differences were found except for items 3 and 4. There was also a significant difference in satisfaction of present ejaculation with mean scores of 1.3 and 2.9. As a result of examining the clinical severity and the total score, the total score of 5-6 was considered severe, 7-9 moderate, 10-13 mild ejaculation disorder, and 14-15 within the normal range. Conclusion Although our ejaculation function score is still in the developmental stage, we believe that it can be a screening tool for ejaculation function in practical medical care and self-assessment. Disclosure Work supported by industry: no.

The Impact of High Ambient Temperature on Human Sperm Parameters: A Meta-Analysis.

Background:Global warming, lifestyle, or working in a high temperature environment leads to have increased health risk factors. This meta-analysis was conducted to determine the impact of high ambient temperature on male reproductive function.Methods:Scientific articles were screened in the database including MEDLINE, EMBASE, National center for biotechnology information (NCBI) or Web of Science with relating keywords. Impact data of high ambient temperature on semen parameters were extracted and analyzed by STATA software according to the Random Effects Model. The high ambient temperature exposure group and Non-exposure group were compared using the standard mean difference (SMD). Publications were evaluated for publication bias by Egger test.Results:Nine articles were finally selected from databases examining the effect of high ambient temperature on male reproductive health of 356 men from Iran, Italy, Thailand, China, Egypt. High ambient temperature showed a significant decrease in the seminal parameters, semen volume during each ejaculation (SMD = −0.74; 95% CI −1.11, −0.36), sperm concentration (SMD = −1.07; 95% CI −1.42, −0.72), total sperm count (SMD = −1.52; 95% CI −2.96, −0.08), sperm motility (SMD = −1.93; 95% CI −2.83, −1.04), sperm progressive motility (SMD = −1.65; 95% CI −2.39, −0.91) and normal morphology (SMD = −2.41; 95% CI −3.30, −1.52).Conclusion:High ambient temperature negatively affects sperm quality, including decreased semen volume, sperm count, sperm concentration, motility and normal morphology. This might lead to protective strategies to avoid the adverse effects of high ambient temperature on male fertility.

A Systemic Review and Meta-analysis of the Effect of SARS-CoV-2 Infection on Sperm Parameters

Objective . Several studies examined the putative effects of SARS-CoV-2 infection on sperm parameters. However, the results remain controversial. In this study, we conducted the most up-to-date systematic review and meta-analysis to investigate the effect of SARS-CoV-2 infection on sperm quality in COVID-19-positive and COVID-19-negative male participants. Method . Seven databases were searched for literature released through June 10, 2022, containing estimates for the outcomes of interest. Using a random-effects model (REM) or a fixed-effects model (FEM), we analyzed the pooled results. The quality of all included studies was assessed by the Newcastle-Ottawa scale. In addition, we performed a quantitative and subgroup analysis of semen data across all included studies. Results . Fourteen studies were extracted from 10 publications, involving a total of 1174 participates for meta-analysis. Sperm parameters of 521 COVID-19 male patients and 653 controls were analyzed. In 8 case-control studies, the pooled mean difference (MD) of total sperm motility was -5.37% (95% confidence interval (CI): -8.47 to -2.28; p &lt; 0.05 ), suggesting that total motility was significantly impaired in male COVID-19 cases. Subgroup analysis showed a significant decrease in semen volume, sperm concentration, and total motility in 238 patients with a recovery time of less than 90 days. Moreover, in the other 6 included pre- to post-COVID-19 studies, the pooled MDs of sperm concentration, total sperm count, total motility, progressive motility, and normal morphology were − 6.54 × 10 6 /ml (95% CI: -10.27 to -2.81; p &lt; 0.05 ), − 38.89 × 10 6 (95% CI: -59.20 to -18.58; p &lt; 0.05 ), -7.21% (95% CI: -14.36 to -0.07; p &lt; 0.05 ), -5.12% (95% CI: -8.71 to -1.53; p &lt; 0.05 ), and -1.52% (95% CI: -2.88 to -0.16; p &lt; 0.05 ), respectively, which indicate SARS-CoV-2 infection significantly affected these five sperm parameters. Conclusion . Our results revealed that SARS-CoV-2 infection was significantly correlated with decreased sperm quality. Of six sperm parameters, total motility and sperm concentration were the most significantly decreased parameters. These results suggest a possible negative influence of SARS-CoV-2 infection on testicular function and male fertility. Given the potential detrimental effect of SARS-CoV-2 on semen quality, male reproductive health should be monitored closely in patients with COVID-19. This trial is registered with CRD42021275823 .

The adverse association between stimulant use for attention deficit hyperactivity disorder (ADHD) and semen parameters.

This study examined the relationship between stimulant medications used for the treatment of attention deficit hyperactivity disorder and semen parameters. We performed a retrospective cohort study at a large, academic institution between 2002 and 2020. We included men with a semen analysis without prior spermatotoxic medication use, empiric medical therapy exposure or confounding medical diagnoses (varicocele, Klinefelter's syndrome, cryptorchidism, cystic fibrosis, diabetes, cancer or cancer-related treatment, and azoospermia). Men were stratified by stimulant exposure (methylphenidate or amphetamines). A multivariable linear regression was fit to assess the association between individual semen parameters, age, stimulant exposure and non-stimulant medication use. Of 8,861men identified, 106men had active prescriptions for stimulants within 90days prior to semen testing. After controlling for age and exposure to non-stimulant medications, stimulant use was associated with decreased total motile sperm count (β: -18.00mil/ejaculate and standard error: 8.44, p=0.033) in the setting of decreased semen volume (β: -0.35ml, and standard error: 0.16, p=0.035), but not sperm concentration, motility and morphology. These findings suggest a role for reproductive physicians and mental health providers to consider counselling men on the potential negative impact of stimulants prescribed for attention deficit hyperactivity disorder on semen volume during fertility planning.

Effect of Acacia mearnsii Tannin Extract Supplementation on Reproductive Performance and Oxidative Status of South African Mutton Merino Rams.

Simple SummaryNutrition and the seasons are two of the better-known variables that affect the reproductive performance of farm animals. In recent years, many antioxidants have been proposed as a tool to improve male reproductive performance. Although such antioxidants, in most cases, are expensive and artificial, tannin extract presents a cheap and natural source of antioxidants. This research evaluated the supplementation effects of tannin extract (TE) and encapsulated tannin extract (ETE) on testicular measurements, semen quality, hormonal status, and oxidative status, as well as the seasonal effect on the testicular measurements of South African Mutton Merino rams. The results suggest that the encapsulation may afford the maximum benefit of TE on sperm concentration and motility. Treatments did not affect the hormonal and oxidative status. The testicular measurements were significantly higher in autumn compared to winter. The plasma level of cortisol correlates negatively with sperm mass motility, progressive motility, viability, and acrosome integrity.We investigated the supplementation effects of Acacia mearnsii tannin extract (TE) and encapsulated tannin extract (ETE) on reproductive performance and oxidative status of South African Mutton Merino rams. We also observed the season effect on the testicular measurements. Thirty rams were divided into five groups: 0.0 g TE (control), 1.5 g TE, 3 g TE, 1.5 g ETE, and 3 g ETE supplemented daily for 16 weeks transiting from autumn to winter. Bodyweight and testicular measurements were recorded biweekly. Semen and blood samples were collected weekly during the last five weeks of supplementation. Results showed that the increase in the ETE from 1.5 to 3 g increased the testicular length and sperm concentration, as well as decreased the percentages of low and non-progressive spermatozoa (). Simultaneously, the increase in the TE from 1.5 to 3 g decreased semen volume and elevated the percentage of abnormal sperm (). The results suggest that the encapsulation of TE affords the maximum benefit of the TE on the sperm quality. Treatments did not affect the hormonal and oxidative status. Testicular measurements were significantly higher in autumn compared to winter. The plasma level of cortisol significantly correlates negatively with sperm motility, viability, and acrosome integrity.

Does COVID-19 Worsen the Semen Parameters? Early Results of a Tertiary Healthcare Center

Introduction: The coronavirus disease 2019 (COVID-19) is a global pandemic which may affect multiple organs and systems including testes and disrupt the gonadal functions. The current study aimed to evaluate the effect of COVID-19 on the semen parameters and sex-related hormone levels in infertile men. Methods: The study included 21 patients who were evaluated in Ankara City Hospital, Andrology Clinic, for male infertility and have had the diagnosis of COVID-19. All the patients were evaluated in terms of semen parameters. The follicle-stimulating hormone, luteinizing hormone, and testosterone (T) levels were also evaluated in 8 of the patients. The results were presented through 2 dependent group analyses, based on the data of the patients collected before and after the diagnosis of COVID-19. Results: None of the patients needed to be hospitalized at any time through the course of COVID-19. There was a significant decrease in semen volume, percentage of total motility, percentage of progressive motility, and normal sperm morphology after COVID-19 (3 [1–8] vs. 2.5 [1.5–5], p = 0.005; 48.6 ± 22.1 vs. 34.7 ± 20.7, p = 0.001; 35.1 ± 21.7 vs. 21.8 ± 15.9, p < 0.001; 6 [3–24] vs. 5 [3–18], p = 0.015; respectively). There was also a significant decline in T level of the patients after the diagnosis of COVID-19 (350.1 ± 115.5 vs. 289.8 ± 103.3, p = 0.009). Conclusion: COVID-19 may have unfavorable effects on the gonadal functions and may lead to further deterioration of the semen parameters in infertile men, which should be considered through the evaluation for infertility.